Daniel A.J. Bow

Localization of P-gp (Abcb1) and Mrp2 (Abcc2) in Freshly Isolated Rat Hepatocytes

Daniel A.J. Bow, Jennifer L. Perry, David S. Miller et al. · Drug Metabolism and Disposition · 2007 · 106 citations · Full text

Pharmacy, Biochemistry, Pharmacology +17

Mechanistic Physiologically Based Pharmacokinetic Modeling of the Dissolution and Food Effect of a Biopharmaceutics Classification System IV Compound—The Venetoclax Story

Arian Emami Riedmaier, David Lindley, Jeffrey A. Hall et al. · Journal of Pharmaceutical Sciences · 2017 · 77 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Prediction of Clinical Drug–Drug Interactions of Veliparib (ABT-888) with Human Renal Transporters (OAT1, OAT3, OCT2, MATE1, and MATE2K)

Ryota Kikuchi, Yanbin Lao, Daniel A.J. Bow et al. · Journal of Pharmaceutical Sciences · 2013 · 64 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

The Impact of Plasma Protein Binding on the Renal Transport of Organic Anions

Daniel A.J. Bow, Jennifer L. Perry, John D. Simon et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 43 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Mechanisms and Predictions of Drug-Drug Interactions of the Hepatitis C Virus Three Direct-Acting Antiviral Regimen: Paritaprevir/Ritonavir, Ombitasvir, and Dasabuvir

Mohamad Shebley, Jinrong Liu, Olga Kavetskaia et al. · Drug Metabolism and Disposition · 2017 · 41 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17